Document Type
Conference Proceeding
Publication Date
5-13-2022
Abstract
Anti-NMDA receptor encephalitis is a progressively debilitating, clinically heterogeneous, frequently fatal disease caused by autoantibodies directed against the N-methyl-D-aspartate receptor that affects 1 in 1.5 million people each year. Risk of misdiagnosis or delayed treatment is high due to variable presentations and potential false negative results.
Recommended Citation
Cascardo C, Ismail A, Marijanovich N, Davila F. 9-month course of refractory anti-NMDA receptor encephalitis with initial negative markers: diagnostic and therapeutic challenges. Abstract presented at: American College of Physicians Michigan Chapter Residents Day / Medical Students Day; 2022 May 13; Dearborn, MI.
Comments
American College of Physicians Michigan Chapter Residents Day / Medical Students Day, May 13, 2022, Dearborn, MI.